LD/CD Infusion Improves "ON" Time, Outcomes in Parkinson's

Offering levodopa/carbidopa as a 24-hour continuous subcutaneous infusion could help to improve treatment on times and motor experiences of daily living compared with oral preparations.
Medscape Medical News

source https://www.medscape.com/viewarticle/996240?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost